SK12542002A3 - Riadený systém prísunu liečiva na orálne podávanie ciprofloxacínu raz denne - Google Patents

Riadený systém prísunu liečiva na orálne podávanie ciprofloxacínu raz denne Download PDF

Info

Publication number
SK12542002A3
SK12542002A3 SK1254-2002A SK12542002A SK12542002A3 SK 12542002 A3 SK12542002 A3 SK 12542002A3 SK 12542002 A SK12542002 A SK 12542002A SK 12542002 A3 SK12542002 A3 SK 12542002A3
Authority
SK
Slovakia
Prior art keywords
ciprofloxacin
weight
formulation
agent
xanthan gum
Prior art date
Application number
SK1254-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Naresh Talwar
John N. Staniforth
Ashok Rampal
Gour Mukherji
Badri N. Vishwanathan
Brij Khera
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of SK12542002A3 publication Critical patent/SK12542002A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1254-2002A 2000-03-03 2001-02-28 Riadený systém prísunu liečiva na orálne podávanie ciprofloxacínu raz denne SK12542002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (1)

Publication Number Publication Date
SK12542002A3 true SK12542002A3 (sk) 2003-05-02

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1254-2002A SK12542002A3 (sk) 2000-03-03 2001-02-28 Riadený systém prísunu liečiva na orálne podávanie ciprofloxacínu raz denne

Country Status (31)

Country Link
EP (1) EP1263409A1 (hr)
JP (1) JP2003525229A (hr)
KR (1) KR20030009374A (hr)
CN (1) CN1420763A (hr)
AP (2) AP2001002084A0 (hr)
AR (1) AR032614A1 (hr)
AU (1) AU3589701A (hr)
BG (1) BG107055A (hr)
BR (1) BR0108958A (hr)
CA (1) CA2400950A1 (hr)
CZ (1) CZ20022883A3 (hr)
DO (1) DOP2001000130A (hr)
EA (1) EA200200914A1 (hr)
EC (1) ECSP013952A (hr)
EE (1) EE200200497A (hr)
GT (1) GT200100033A (hr)
HN (1) HN2001000038A (hr)
HR (1) HRP20020715A2 (hr)
HU (1) HUP0204417A3 (hr)
IL (1) IL151553A0 (hr)
IS (1) IS6532A (hr)
MX (1) MXPA02008568A (hr)
NO (1) NO20024108L (hr)
NZ (1) NZ520927A (hr)
OA (1) OA12381A (hr)
PE (1) PE20011113A1 (hr)
PL (1) PL365071A1 (hr)
SK (1) SK12542002A3 (hr)
WO (1) WO2001064183A1 (hr)
YU (1) YU66202A (hr)
ZA (1) ZA200206764B (hr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1745775B1 (en) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
WO2016115253A1 (en) 2015-01-14 2016-07-21 The Regents Of The University Ofcolordo, A Body Corporate Insulin mimotopes and methods of using the same
EP3419669A4 (en) * 2016-02-23 2019-10-30 Matripharm International Inc. DOUBLE-SPEED RELEASE COMPOSITION WITH HIGH MEDICAL DRUG CHARGE
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE19839057A1 (de) * 1998-08-28 2000-03-02 Koch Berthold Spülluft-Regler für eine Trockenvorrichtung für Druckluft
EA004443B1 (ru) * 1998-09-14 2004-04-29 Рэнбакси Лабораториз Лимитед Лекарственная форма для контролируемого высвобождения ципрофлоксацина для приема один раз в день

Also Published As

Publication number Publication date
OA12381A (en) 2004-09-06
CZ20022883A3 (cs) 2003-04-16
KR20030009374A (ko) 2003-01-29
WO2001064183A1 (en) 2001-09-07
IS6532A (is) 2002-08-28
EP1263409A1 (en) 2002-12-11
CN1420763A (zh) 2003-05-28
HN2001000038A (es) 2005-03-23
NO20024108D0 (no) 2002-08-28
AU3589701A (en) 2001-09-12
BG107055A (bg) 2003-06-30
MXPA02008568A (es) 2003-02-24
HRP20020715A2 (en) 2004-12-31
AP2002002627A0 (en) 2002-09-30
IL151553A0 (en) 2003-04-10
PL365071A1 (en) 2004-12-27
AP1485A (en) 2005-10-31
NO20024108L (no) 2002-10-25
GT200100033A (es) 2001-10-25
HUP0204417A2 (en) 2003-05-28
AR032614A1 (es) 2003-11-19
CA2400950A1 (en) 2001-09-07
PE20011113A1 (es) 2001-10-14
YU66202A (sh) 2005-09-19
EA200200914A1 (ru) 2003-02-27
ZA200206764B (en) 2003-03-04
BR0108958A (pt) 2003-09-30
HUP0204417A3 (en) 2005-03-29
NZ520927A (en) 2003-06-30
DOP2001000130A (es) 2004-03-31
JP2003525229A (ja) 2003-08-26
AP2001002084A0 (en) 2001-03-31
EE200200497A (et) 2004-02-16
ECSP013952A (es) 2002-04-23

Similar Documents

Publication Publication Date Title
US6261601B1 (en) Orally administered controlled drug delivery system providing temporal and spatial control
AU758324B2 (en) Orally administered controlled drug delivery system providing temporal and spatial control
US6899896B2 (en) Hydrogel-driven layered drug dosage form
SK12542002A3 (sk) Riadený systém prísunu liečiva na orálne podávanie ciprofloxacínu raz denne
EP2386302A1 (en) A controlled release pharmaceutical dosage form of trimetazidine and processes for the preparation thereof
AU2006201553A1 (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin
US20080206338A1 (en) Controlled release formulations of an alpha-adrenergic receptor antagonist
AU2021362683A1 (en) Gastro retentive dosage forms comprising deutetrabenazine
MC MK et al. preparation thereof